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Background: Lipoproteins are the major agonists of Wolbachia-dependent inflammatory pathogenesis in filariasis
and a validated target for drug discovery. Here we characterise the abundance, localisation and serology of the
Wolbachia lipoproteins: Wolbachia peptidoglycan associated lipoprotein and the Type IV Secretion System
component, VirB6.
Methods: We used proteomics to confirm lipoprotein presence and relative abundance; fractionation,
immunoblotting and confocal and electron immuno-microscopy for localisation and ELISA for serological analysis.
Results: Proteomic analysis of Brugia malayi adult female protein extracts confirmed the presence of two
lipoproteins, previously predicted through bioinformatics: Wolbachia peptidoglycan associated lipoprotein
(wBmPAL) and the Type IV Secretion System component, VirB6 (wBmVirB6). wBmPAL was among the most
abundant Wolbachia proteins present in an extract of adult female worms with wBmVirB6 only detected at a much
lower abundance. This differential abundance was reflected in the immunogold-labelling, which showed wBmPAL
localised at numerous sites within the bacterial membranes, whereas wBmVirB6 was present as a single cluster
on each bacterial cell and also located within the bacterial membranes. Immunoblotting of fractionated extracts
confirmed the localisation of wBmPAL to membranes and its absence from cytosolic fractions of C6/36 mosquito
cells infected with wAlbB. In whole worm mounts, antibody labelling of both lipoproteins were associated with
Wolbachia. Serological analysis showed that both proteins were immunogenic and raised antibody responses in the
majority of individuals infected with Wuchereria bancrofti.
Conclusions: Two Wolbachia lipoproteins, wBmPAL and wBmVirB6, are present in extracts of Brugia malayi with
wBmPAL among the most abundant of Wolbachia proteins. Both lipoproteins localised to bacterial membranes
with wBmVirB6 present as a single cluster suggesting a single Type IV Secretory System on each Wolbachia cell.
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Wolbachia are one of the most abundant intracellular
symbiotic bacteria in nature. They are most common in
terrestrial arthropods, with up to 40% of species infected,
and are also found in a sub-group of filarial nematodes,
where they have evolved a mutualistic association [1,2]. In
filarial nematodes Wolbachia are essential for normal lar-
val growth and development, embryogenesis and the sur-
vival of adult worms. Loss of Wolbachia induces extensive
apoptosis of germline and somatic cells, presumably due
to the lack of provision of an essential nutrient or metab-
olite required to prevent apoptosis of these cells and tis-
sues during periods of high metabolic demand [3]. This
mutualistic association has been exploited as a target for
antibiotic therapy, which can cure patients infected with
Wuchereria bancrofti and Onchocerca volvulus, providing
an alternative treatment and control strategy [1,4,5].
In addition to their essential role in the biology of
filarial nematodes, Wolbachia are a major driver of the
inflammatory pathogenesis of filarial disease [6]. Previ-
ous studies have determined that the pro-inflammatory
capacity of Brugia malayi and Onchocerca volvulus is
dependent on the presence of Wolbachia and the mo-
lecular ligands responsible have been characterised as
lipoproteins [7]. The induction of innate and adaptive
inflammatory responses is dependent on recognition by
Toll-like receptors 2 and 6 (TLR2/6) [7,8], pattern rec-
ognition receptors for di-acylated bacterial lipoproteins.
Analysis of the Wolbachia B. malayi (wBm) genome re-
vealed the absence of the gene for the apolipoprotein N-
acyltransferase (Lnt), which converts di- to tri- acylated
bacterial lipoprotein in gram-negative bacteria, suggest-
ing lipoproteins in Wolbachia are di-acylated accounting
for their recognition by TLR2/6 [7].
Bioinformatic analysis of wBm genome using three dis-
tinct databases consistently identified only two lipoproteins
[7]: 1) Wolbachia peptidoglycan-associated lipoprotein
(wBmPAL) and 2) Wolbachia VirB6 (wBmVirB6), which is
a core component of the bacterial Type IV secretion sys-
tem (TIVSS) [9]. Furthermore, a chemically synthesised
Wolbachia PAL di-acylated lipopeptide replicated the
inflammatory activity of whole Wolbachia and soluble
parasite extracts [7]. Here, we have further charac-
terised these two Wolbachia lipoproteins to determine
their relative abundance, structural localisation in the filar-
ial nematode Brugia malayi (naturally infected with wBm)
and Ae. albopictus cell line (C6/36 infected with wAlbB)
and serology in people infected withW. bancrofti.
Methods
Parasite material, mosquito cell line culture and patient
serum
Adult B. malayi cultivated in the peritoneal cavity of jirds
(Meriones unguiculatus) were derived from TRS Laboratories(Athens, Georgia, USA) and maintained at the Liverpool
School of Tropical Medicine. Infected animals received
tetracycline at 2.5 mg/ml in drinking water for a period of
6 weeks. Control infected jirds were maintained in a simi-
lar fashion but without the tetracycline. Two weeks after
the end of the treatment, worms were collected from the
peritoneal cavities using preheated (37°C) culture medium
RPMI-1640 (GIBCO). All procedures involving the use
of laboratory animals were approved by the Ethics and
Animal Care Committees of the University of Liverpool
and Liverpool School of Tropical Medicine, and were car-
ried out according to the Animals (Scientific Procedures)
Act (UK Home Office).
Ae. albopictus mosquito cell lines C6/36 (wAlbB) infected
with Wolbachia strain wAlbB and non-infected C6/36 (NI)
are maintained in culture at the Liverpool School of Trop-
ical Medicine, Liverpool, UK [10]. Cells were cultivated
routinely in 25 cm2 plastic culture flasks at 26°C in 5 ml of
Leibovitz-15 medium containing 2 mM L-glutamine (Life
Technologies), 1% non-essential amino acids, 2% tryptose
phosphate broth, 50 U/ml penicillin, 50 μg/ml streptomycin
(Sigma) and 5% heat-inactivated FBS (Perbio). Cells were
sub-cultured into new flasks every 4–5 days.
Serum samples from W. bancrofti infected individuals
were collected as part of a clinical trial in Tanzania. The
samples used for serology were collected prior to any drug
treatment. The study was approved by the ethics research
committees of the National Institute for Medical Research,
Dar es Salaam, Tanzania, and the Liverpool School of
Tropical Medicine, Liverpool, UK. Written and oral in-
formed consent was obtained from all participants [11].
Fractionation of mosquito cells
Mosquito cells were homogenised in PBS buffer by vortex-
ing with 3 mm borosilicate glass beads. Homogenates were
then centrifuged for 5 min at 300 × g to eliminate cell deb-
ris. Supernatants containing intracellular components were
pelleted by centrifugation at 8,150 × g for 5 min, and re-
suspended in 330 μl PBS. Cellular suspensions were soni-
cated on ice for a period of 1 min (1 s run/2 s pause) at
1,800 J (cumulative value). The supernatants were pooled
and cellular complexes were removed by centrifugation at
8,150 × g for 10 min. The supernatant was overlaid on
1 ml of sucrose solution and cellular membranes were pel-
leted from the supernatants by ultracentrifugation in TLA-
100 (Beckman) at 430,000 × g for 1 h at 4°C. The proteins
were precipitated from the supernatant to obtain the cyto-
solic fraction and from the pellet for the membrane frac-
tion using acetone. Samples were stored at –80°C until use.
Western blot
Antibodies to wBmPAL were generated as described pre-
viously [9]. Anti-VirB6 antibodies were produced by
New England Biolabs, (USA) using a similar procedure.
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and untreated jirds, washed three times in PBS and pro-
teins were extracted using sonication. Fractions of C6/36
cells and intact cell pellets were collected in the separate
tubes and proteins were extracted using sonication. The
protein concentration was estimated by bicinchoninic acid
assay (Invitrogen) following the manufacturer’s instruc-
tions. Protein extracts of worms were mixed with LDS
sample buffer (NuPAGE; Invitrogen), boiled, and run with
a 12% PAGE gel. Protein was transferred to nitrocellulose
membranes and used in the Western blot as previously
described [12].
Microscopy
B. malayi adult females were fixed using 4% formaldehyde
in PBS with 0.05% Triton-X100 (PBST) for 20 min for
confocal microscopy analysis of the localisation of the pro-
teins. During fixation, worms were cut to improve diffu-
sion of the fixative and antibodies. Samples were then
washed three times in PBST and treated with RNase A
(100 μg/ml) at 36°C for 1 h. Then samples were washed in
PBS and blocked with 5% BSA for 15 min and incubated
overnight at 4°C with anti-VirB6 antibody diluted 1:200.
Secondary antibody labelled with FITC was used at 1:500.
After incubation with antibodies samples were co-stained
with propidium iodide for 20 min to visualise DNA (host
nuclei and Wolbachia) and were viewed with an LSM 5
Pascal confocal microscope (Zeiss).
For immuno-TEM, worms and C6/36 cells were fixed
by 4% paraformaldehyde dissolved in PBS for 4 h at 4°C.
During fixation, worms were cut. After fixation, samples
were washed in PBS (three times on ice). Fixed mosquito
cells were embedded into low-melting agarose. All sam-
ples were then dehydrated in a series of ethanol concen-
trations (50–100%) on ice. Dehydrated samples were
embedded in Lowicryl Gold plastic resin. Ultrathin sec-
tions were blocked using 5% BSA and incubated with pri-
mary antibodies diluted 1:100 in 1% BSA overnight at 4°C.
The next day, sections were washed three times in PBS
and incubated with secondary antibody labelled with
15 nm gold particles. Sections were washed and contrasted
using uranyl acetate (1%) and lead citrate and analysed
under the Tecnai G2 Spirit BioTWIN TEM (the TEM
unit, University of Liverpool, UK). For TIVSS analysis ser-
ial sections were taken every 70-90 nm to cover the entire
bacterial cell of non-dividing Wolbachia.
High resolution mass spectrometric analysis of total
parasite protein
Proteomics
For proteomic analysis, a total of 18 adult female B. malayi
were collected by washing out the peritoneal cavity of
Mongolian jirds (Meriones unguiculatus) with warm RPMI
1640 media not containing FBS. Worms were processed bysonication (in 25 mM ammonium bicarbonate) at 70%
amplitude for 30 s with 30 s rest on ice (a total of three cy-
cles). Proteins were treated with the surfactant 0.1% (v/v)
RapiGestTM (Waters) at 80°C for 10 min followed by re-
duction with diothiothreitol (DTT) at a final concentration
of 3 mM (60°C for 10 min) and alkylation with iodoaceta-
mide (IAA) at a final concentration of 50 mM (room temp,
in the dark, 1 h). The enzyme trypsin (sequencing grade,
Promega) was added at an enzyme: substrate ratio of
1:50 and incubated overnight at 37°C. The surfactant was
inactivated the following day by treatment with 0.1% tri-
fluoroacetic acid (TFA) (37°C for 1 h), peptides were recov-
ered following centrifugation at 13,0000 g. A proportion of
unfractionated peptide sample was retained for mass spec-
trometric analysis. A total of 150 μg of digested protein ma-
terial was subjected to extensive fractionation over the pH
range 3-10 using the Agilent 3100 OFFGEL fractionator
system as per manufacturer’s instructions.
Reversed-phase liquid chromatography- tandem mass
spectrometry (RPLC-MSMS)
Both the unfractionated and fractionated peptide samples
were separated by RPLC using a DIONEX UltiMateTM
3000LC chromatography system and MSMS analysis per-
formed on an LTQ Orbitrap Velos using Xcalibur software
v2.1 (Thermo Scientific, UK). Peptides (10 μl = ~500 ng)
were injected onto the analytical column (Dionex Acclaim®
PepMap RSLC C18, 2 μm, 100 Å, 75 μm i.d. × 15 cm,
nanoViper.), which was maintained at 35°C and at a nano-
flow rate of 0.3 μlmin-1. Peptides were separated over linear
chromatographic gradients composed of buffer A (2.5%
acetonitrile [ACN]: 0.1% formic acid [FA]) and buffer B
(90% ACN: 0.1% FA). Two gradients, 60 (3-50% buffer B in
40 min) and 180 min (3-60% buffer B in 140 min), were
employed for analysis. Full scan MS spectra were acquired
over the m/z range of 350-2000 in positive polarity mode
by the Orbitrap at a resolution of 30,000. A data-
dependent Top20 collision induced dissociation (CID) data
acquisition method was used. The ion-trap operated with
CID MSMS on the 20 most intense ions (above the mini-
mum MS signal threshold of 500 counts).
Protein identification
All MSMS data generated was searched against a custo-
mised database for Wolbachia (wBm) and B. malayi
(concatenated from .fasta files obtained from UniProtKB
www.uniprot.org, downloaded on 14/01/2013) using
the search engine MASCOT and Proteome Discoverer
software v1.2 (Thermo Scientific, UK). Search parame-
ters included a precursor mass tolerance of 10 ppm and
fragment ion tolerance 0.8 Da with one tryptic missed
cleavage permitted. Carbamidomethyl (C) was set as a
static modification with oxidation of methionine (M),
deamidation (N, Q) and phospho (ST) (Y) set as dynamic
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peptide confidence filters applied to the dataset (ion scores
p < 0.05/FDR 5%).
IgG antibody ELISA
Flat-bottomed 96-well ELISA plates (Immulon®4HBX
ultra high binding polystyrene microtiter plates) were
coated overnight at 4°C with 50 μl/well of 5 μg/ml of
Wolbachia (PAL and VirB6) recombinant proteins di-
luted in carbonate-bicarbonate buffer, pH 9.6. Plates
were covered with plastic film to prevent drying. The
following day, plates were blocked with 5% skimmed
milk powder in PBST (0.05% Tween 20 in PBS, pH 7.4),
covered as previously and incubated for 1 h at 37°C.
Plates were then inverted and washed with PBST. Hu-
man serum samples (50 μl/well), at a final dilution of
1:200 in blocking buffer, were added to the plates, which
were then covered and incubated for 2 h at room
temperature (RT). Plates were inverted and washed.
50 μl/well of primary antibody murine anti-human IgG
(1 mg/ml; Skybio, UK) diluted 1:1000 in PBST were
added to separate plates, which were then covered and
incubated for 1 h at RT. After inversion and washing,
75 μl/well of secondary antibody anti-murine rabbit IgG
conjugated with horseradish peroxidase (HRP) at 1 mg/ml
(Invitrogen) diluted 1:2000 in PBT was added to each
plate. Plates were covered and incubated for 1 h at RT.
After inversion and washing, 100 μl/well of TMB substrate
and chromogen solution (Sigma) was added to each plate
and these were incubated at RT in the dark until the reac-
tion was stopped after 30 min by adding 50 μl/well of 1 M
H2SO4. The values of optical density were read at 450 nm
wavelength. Cut-off values were then defined as three
times the standard deviation plus the mean of the Euro-
pean control sera for each antigen tested. The Mann
Whitney test (used to compare the differences in median
antibody levels between the different clinical groups) was
carried out using GraphPad Prism (5.0a Mac OS X).
Results
Identification ofWolbachia lipoproteins in Brugia malayi adult
female worms by proteomic and mass spectrometric analysis
Using a global proteomics approach coupled with high
resolution mass spectrometric analysis of protein extract,
we were able to confirm the presence of two predicted
Wolbachia lipoproteins in adult female B. malayi. We have
detected outer membrane protein, PAL (Wbm0152) and
TIVSS, VirB6 components (Wbm0794) with high confi-
dence, following manual validation of MSMS data. Wolba-
chia proteins have been ranked according to protein
sequence coverage observed and the top 20 proteins from
this ranked list are shown in Figure 1. The highest de-
gree of lipoprotein sequence coverage was observed for
PAL (~20%) with VirB6 (Wbm0794) confirmation basedupon single peptide identification, with reduced (<1%)
protein sequence coverage. We were also able to suc-
cessfully differentiate between two paralogues of the
TIVSS components, VirB6 (Wbm0793 and Wbm0794)
by unique peptide identification. Both paralogues were
identified with similar reduced (<1%) protein sequence
coverage. Paralogue Wbm0793 was not predicted as a
lipoprotein by any of the bioinformatic tools used in this
study (Database of Lipoproteins, LIPO, LipoP).
Localisation of Wolbachia Peptidoglycan-Associated
Lipoprotein (wPAL) in Aedes albopictus mosquito cells
and Brugia malayi adult worms
We used an affinity purified polyclonal rabbit anti-
wBmPAL antibody to perform western blot analysis of
the proteins extracted from the Wolbachia-infected mos-
quito cell line C6/36 (wAlbB) and B. malayi (wBm) fe-
males. As demonstrated previously, protein extracts from
B. malayi females showed a single band at 17 kDa, which
was lost following depletion of Wolbachia with tetracycline
(Figure 2A, [9]). Aedes albopictus mosquito cells (C6/36
line) were crushed to extract total proteins, cytosolic pro-
tein fractions, and membrane protein fractions for western
blot analysis (Figure 2B). The crude extract of the cells in-
fected with wAlbB and the membrane fraction from C6/36
(wAlbB) showed positive signals for PAL, whereas the cyto-
solic fraction from C6/36 (wAlbB) showed no reactivity. A
slight difference in migration of PAL in lanes 3 and 4 may
relate to differences in preparation of the extracts with
enriched membrane proteins running slightly slower in the
gel. Non-infected C6/36 (NI) cells were used as a negative
control and the protein extracts from all fractions showed
no wPAL reactivity (Figure 2B).
Next we investigated the ultrastructural localisation of
wBmPAL in B. malayi females using transmission electron
microscopy. We observed a specific localisation of anti-
wBmPAL antibodies to the membranes of Wolbachia
(Figure 2C, D). Immunogold particles were not observed
on the membranes of vacuoles containing Wolbachia.
Statistical analysis of the distribution of immunogold parti-
cles on the sections of B. malayi lateral cord showed 86%
of all counted particles located on the bacterial membrane
and only 14% in the cytoplasm of the host cell (Table 1).
The low number of immunogold particles that were ran-
domly distributed in the cytoplasm represented the level of
background staining and this level was similar in all the
control experiments (tetracycline treated B. malayi and
Wolbachia-free Acanthocheilonema viteae, Table 1).
Localisation of Wolbachia VirB6, a core component of
Type IV Secretion System in Aedes albopictus mosquito
cells and Brugia malayi adult worms
Antibodies raised to wBmVirB6, were unsuitable for west-
ern blot analysis due to non-specific binding. Immunogold
Figure 1 Analysis of the Wolbachia proteome of adult female Brugia malayi. Wolbachia proteins identified by proteomic and high
resolution mass spectrometric analysis were filtered to report only high/medium confidence peptides then ranked according to protein sequence
coverage observed (top 20 shown). The presence of predicted lipoprotein, Peptidoglycan-Associated Lipoprotein (Wbm0152), was confirmed by
spectral matching of MSMS data against a customised protein sequence database to two unique tryptic peptides (MASCOT ion scores p < 0.05/FDR
5%) constituting 20.13% total protein sequence coverage; it is positioned within the top 10 proteins in this ranked list (*).
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determined using immuno-TEM analysis of B. malayi
females and C6/36 (wAlbB) cells. Wolbachia VirB6
protein localised as a single discreet cluster(s) on the
Wolbachia membranes (Figure 3A, B). In addition, oc-
casional immunogold labelling was also observed local-
ised within the bacterial matrix (Figure 3C, D), which
could represent a precursor of the protein synthesised
in bacteria. This pattern of protein distribution was
similar in somatic cells and developing embryos of
B. malayi (Figure 3A-D). Serial sections of bacteria de-
termined that the VirB6 protein clusters as a single
complex established in bacterial membranes and on
some sections near the pole of bacteria. In some cases
Wolbachia had two clusters, which were located on the
opposite poles prior to division.
Confocal microscopy
To determine whether the protein localisation was asso-
ciated with Wolbachia location in whole organisms or
cells, we used whole mount confocal microscopy. The
location of antibodies to both wBmPAL and wBmVirB6
were associated with Wolbachia (stained by propidium
iodide, Figure 4A-F) in the hypodermal cord cells of
B. malayi. Antibody reactivity was absent from tetracyc-
line treated B. malayi (Figure 4G-I).Serology
Next, we investigated the human IgG response to the
two lipoproteins in people infected with W. bancrofti
from Tanzania. Both Wolbachia lipoproteins showed
high levels and frequency of antibody reactivity in in-
fected individuals (Figure 5) with 98.4% and 82.3% of pa-
tients demonstrating IgG responses to wBmPAL and
wBmVirB6 respectively.
Discussion
Here we show that two Wolbachia lipoproteins, PAL
and VirB6 are located on the membranes of Wolbachia
(wBm and wAlbB). Proteomic analysis of B. malayi adult
female protein extracts confirmed the presence of two
lipoproteins, previously predicted through bioinformat-
ics; Wolbachia peptidoglycan associated lipoprotein
(wBmPAL) and the Type IV Secretion System compo-
nent, VirB6 (wBmVirB6). Using protein sequence cover-
age as an estimate of relative abundance, we showed
that wBmPAL was among the most abundant Wolbachia
proteins present in an extract of adult female worms
with wBmVirB6 only detected at a much lower abun-
dance. This high abundance of PAL has been previously
reported in adults and microfilariae of B. malayi [13] and
O. ochengi [14] in which PAL consistently appears in the
top 10 abundant Wolbachia proteins. This differential
Figure 2 Localisation of PAL on Wolbachia membranes. A, B – Western immunoblot detection of wPAL protein in B. malayi (A) and C6/36
mosquito cell line fractional (B) samples. A. Protein samples of B. malayi infected wBm (1) and B. malayi after six weeks tetracycline treatment (2).
B. Protein samples of infected and non-infected C6/36 cells cultivated in vitro: 1 – total protein extract of non-infected cells, 2 – membrane
fraction of non-infected cells, 3 – total protein extract of cells infected with wAlbB, 4 – membrane fraction of infected cells, 5, 6 – cytoplasmic
fractions of non-infected and infected cells, respectively. M – marker, kDa. C-F – Immuno-transmission electron microphotographs showed
localisation of PAL on the bacterial membrane in cytoplasm of adult B. malayi infected with wBm. b – bacteria. Arrow head indicates membrane
of vacuole containing Wolbachia.
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which showed wBmPAL localised at numerous sites with-
in the bacterial membranes, whereas wBmVirB6 was
present as a single cluster on each bacterial cell and also
located within the bacterial membranes. Immunoblot-
ting of fractionated extracts confirmed the localisation
of PAL to membranes and its absence from cytosolic
fractions of C6/36 mosquito cells infected with the
wAlbB strain.Our observations are consistent with previous studies,
which localise PAL to the membranes of other gram-
negative bacteria such as E. coli [15]. The typical cell en-
velope structure of gram-negative bacteria consists of
three layers: outer and inner membranes with a thin
layer of peptidoglycan (PG) located between the mem-
branes (the periplasmic space). The N-terminus of PAL
containing the lipid moiety is anchored to the inner face
of the outer membrane, with the C-terminus binding to
Table 1 Statistical analysis of gold-dot distribution on the
TEM sections of B. malayi and A. viteae
Immunogold distribution on the sections stained with anti-PAL antibody
Bacteria (mean ± SD, %) Host cytoplasm (mean ± SD, %)
BM 86.6 ± 18.5*, ^, “ 13.4 ± 11.7
BM-TET 0 11.7 ± 5.0
AV 0 5.2 ± 3.0
* - Statistical analysis of means of immunogold particles located on bacterial
material and particles located on host cytoplasm in B. malayi (BM), p-value < 0.01.
^ - Statistical analysis of means of immunogold particles located on bacterial
material in B. malayi (BM) and particles located on host cytoplasm of tetracycline
treated Brugia malayi (BM-TET) p-value < 0.01.
“ - Statistical analysis of means of immunogold particles located on bacterial
material in B. malayi (BM) and particles located on host cytoplasm of A. viteae
(AV) p-value < 0.01.
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outer membrane to PG [16]. However, Wolbachia does
not contain the entire biosynthesis pathway for PG [17],
and electron microscopy analysis of the Wolbachia cell
wall confirms the absence of a PG layer [18,19]. SomeFigure 3 Ultrastructural distribution of Wolbachia VirB6 in lateral cord
showing distribution of Wolbachia VirB6 in lateral cord of Brugia malayi and a
connection in cytoplasm of lateral cord of adult B. malayi, C, D – a single com
E, F – VirB6 on wAlbB bacterial membrane in cytoplasm of mosquito cells (C6components of the biosynthesis of PG are still intact, for
example, lipid II, which, in addition to its role in the cell
envelope architecture, has a role in cell division [11]. In
gram-negative bacteria PAL anchors to the outer mem-
brane but is located in the periplasmic space as part of
the Tol–PAL complex [20,21] and evidence for the exist-
ence of the periplasmic component of the Tol transport
systems (Wbm5057) is found in wBm. This system plays
important roles in the transport of molecules through
the outer membrane of bacteria, in the regulation of the
expansion of membranes and in bacterial sensitivity to
antibiotics [21]. The complex is also involved in the pro-
tection of bacteria against the penetration of phage par-
ticles into the cell and in the formation of cell envelopes
in daughter cells [22,23].
The lipoprotein, VirB6, was also localised to the mem-
branes of Wolbachia in both wAlbB and wBm. In con-
trast to PAL, which was widely distributed throughout
the membranes, VirB6 was localised as a discreet single
complex on the bacterial cell. Through the use of serialof Brugia malayi. Immuno-transmission electron microphotographs
mosquito cell line. A, B – localisation of VirB6 in a bacterium-bacterium
plex of VirB6 detected on the bacterial pole in developing microfilaria,
/36 cell line).
Figure 4 Visualisation of PAL and VirB6 in whole worm mounts of B. malayi. A, B, Wolbachia (small red foci, bacteria DNA stained by
propidium iodide, large red spot, nematode nuclei, see Methods) and PAL (green, secondary antibody labeled by FITC) in lateral cord of filarial
nematode, C, merged A and B. D, E, VirB6 (green) and Wolbachia (small red foci) in B. malayi (wBm). F, merged D and E. G, H, negative
control – Wolbachia-free B. malayi treated with antibiotic (lack of PAL reactivity shown as representation of both antibodies). I, merged G and H.
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tire bacterial cell of non-dividing Wolbachia, we ob-
served that Wolbachia has a single TIVSS complex for
each cell. This is also observed for the TIVSS complex
in Agrobacterium [24-26]. During bacterial division, the
components of the secretion system migrate onto the
pole of Agrobacterium [27,28]. On the micrographs of
the sections for both insect cells and filarial nematodes,
VirB6 was found on the membranes of the Wolbachia
forming a single complex close to the pole of the bacter-
ium. In detailed analysis of immuno-TEM sections, theFigure 5 IgG antibody responses against Wolbachia lipoproteins in p
wBmPAL (A) and virB6 (B). Infected groups both show significantly elevate
controls. The red line represents the cutoff value (mean + 3 X SD).complex of VirB6 proteins on the bacterial membrane
were often observed in close association with the vacu-
olar membrane.
The bacterial VirB6 protein is a core component of
TIVSS and plays important roles in the transfer of
DNA-protein complexes to induce bacterial adaptation
processes, to deliver pathogens into host cytoplasm, and
to establish bacterial effects on host biology [28-31]. In
gram-negative bacteria, TIVSS connects two bacterial
membranes and forms a canal-like structure [30]. Previ-
ous analysis of the Wolbachia VirB6 gene in genomes ofatients infected with Wuchereria bancrofti. IgG reactivity against
d levels of IgG to both lipoproteins (P < 0.05) compared with European
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forms [32]. In this study we identified two isoforms from
proteomic analysis, only one of which (Wbm0794) was
predicted as a lipoprotein by bioinformatics. Computa-
tional analysis of the structure of VirB6 protein revealed
that the 5-7 transmembrane domains were located on the
inner bacterial membrane [30]. The TIVSS is likely to
function as a major pathway for the secretion of bacterial
products, which are involved in the Wolbachia-host sym-
biosis and a number of Wolbachia proteins, including
both lipoproteins, can be detected in the parasite secre-
tome [33]. Rickettsial bacteria related to Wolbachia such
as Anaplasma and Ehrlichia use TIVSS for successful in-
fection of mammalian cells [29].
The lipoprotein biosynthesis pathway of Wolbachia
has been investigated as a potential chemotherapeutic
target for filariasis [34]. Treatment of Wolbachia-infected
mosquito cells with the signal peptidase II (LspA)
inhibitor, globomycin, led to a dose-dependent reduc-
tion in Wolbachia load preceded by an inhibition of
lipoprotein processing. Treatment of B. malayi with glo-
bomycin in vitro resulted in significant reductions in mo-
tility and viability validating this as a target for drug
discovery. Similarly, treatment of the related bacteria
Ehrlichia chaffeensis with globomycin, prevented infection
of HL-60 in vitro, which was associated with inhibition
of lipoprotein processing [35]. PAL specifically has been
implicated in this infection process, as antibodies to PAL
(OmpA) bind to E. chaffeensis and prevent infection of
cells in vitro [36]. Furthermore PAL of Helicobacter pylori,
known as OprL, has been defined as a critical drug tar-
get in silico [37] suggesting that targeting PAL and/or
lipoprotein biosynthesis could deliver broad spectrum
antibiotic activity.
Wolbachia lipoproteins are the agonists of inflamma-
tory pathogenesis of filarial disease through activation of
innate and adaptive immunity via recognition by TLR2/6
[6,7]. Bacterial lipoproteins play an important role in
the pathogenesis of several bacterial infections including
Yersinia pestis, Pseudomonas aeruginosa, Salmonella
enterica, Nesseiria meningitidis, Borrelia burdorferi and
Mycobacterium tuberculosis [38]. In sepsis, E. coli PAL
is a potent TLR2 agonist, which contributes to inflam-
mation, cardiac dysfunction, endothelial activation, coag-
ulopathy, and vascular leakage [39-42]. In filariasis
Wolbachia PAL recruits neutrophils, macrophages and
other innate immune cells, which accumulate around
living Onchocerca adults worms in onchocermata [43,44]
and in response to dying microfilariae in the cornea
[45,46], which stimulates their activation and the pro-
duction of an array of pro-inflammatory cytokines and
mediators [6,9]. Wolbachia lipoproteins also drive adap-
tive Th1 immunity through activation of dendritic cells
[9]. In view of the relative abundance of PAL comparedto VirB6, it seems likely that PAL is the major driver of
Wolbachia-mediated inflammatory immunity. Exposure
of the host to lipoproteins will occur on the release of
Wolbachia on the death of the parasite or through their
presence in the parasite secretome [33]. The high level
and frequency of antibodies against these proteins in pa-
tients infected with W. bancrofti is supportive of their
inherent immunogenicity and exposure to the adaptive
immune system.
Conclusion
Two Wolbachia lipoproteins, wBmPAL and wBmVirB6,
are present in extracts of Brugia malayi with wBmPAL
among the most abundant of Wolbachia proteins. Both
lipoproteins localised to bacterial membranes with
wBmVirB6 present as a single cluster suggesting a single
Type IV Secretory System on each Wolbachia cell. Sero-
logical analysis showed that both proteins were immuno-
genic and raised antibody responses in the majority of
individuals infected with Wuchereria bancrofti.
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